Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2008 Mar 17;65(12):1916–1932. doi: 10.1007/s00018-008-7573-9

The urokinase receptor and integrins in cancer progression

C-H Tang 1, Y Wei 1,
PMCID: PMC11131927  PMID: 18345479

Abstract.

Enhanced levels of expression of urokinase receptor (uPAR) and certain integrins have been linked to cancer cell progression. This has classically been attributed to matrix degradation via the activation of the urokinase (uPA)/plasmin system and modulation of cell motility and survival through integrin engagement. More recently, uPAR has been shown to play multiple roles independent of protease activity. Specifically, uPAR has been shown to be intimately involved in the regulation of cell adhesion, migration and proliferation in part through interactions with other membrane partners, including integrins. The goal of this review is to summarize recent insights in the function of uPAR/integrin interactions, to provide a framework for understanding the importance of these interactions in the context of cancer, and to highlight its potential as a target for therapeutic intervention.

Keywords. Urokinase, urokinase receptor, uPAR, integrins, cancer

Footnotes

Received 17 December 2007; received after revision 29 January 2008; accepted 1 February 2008


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES